Loading
Latest filing published 11 Jul 2022 for Entasis Therapeutics Holdings Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Anna Diaz Triola, listed as senior executive, appears in our data through filings on Entasis Therapeutics Holdings Inc. shares, published by SEC (Form 4). Between 18 January 2022 and 11 July 2022, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 11 July 2022 came the latest disclosure, a transaction in Entasis Therapeutics Holdings Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations